Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Miracor to Report Successful Clinical Study Results of Its PICSO® System Designed to Improve Myocardial Perfusion Following Primary PCI

November 7, 2011 5:45 am | News | Comments

VIENNA--(BUSINESS WIRE)--Miracor Medical Systems GmbH announced today that data will be reported during next week's “TCT (Transcatheter Cardiovascular Therapeutics) 2011” scientific meeting in San Francisco. The data show that the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) system...

Lake Region Medical to Showcase New and Emerging Technologies That Positions the Company as a Premier Development and Manufacturing Partner for Wire-Based Products at Cardiovascular Therapy Meeting

November 4, 2011 6:43 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Lake Region Medical, a global development and manufacturing partner to leading medical device companies, will highlight its original development manufacturing capabilities, services and technologies at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) meeting...

Emboline, Inc. to Debut Game-Changing Embolic Protection Technology for Percutaneous Heart Valve Procedures in San Francisco Next Week

November 4, 2011 6:40 am | News | Comments

FREMONT, Calif.--(BUSINESS WIRE)--Emboline, Inc. (www.emboline.com), an emerging medical device company, will debut its game-changing embolic protection devices for percutaneous heart valve repair and replacement in San Francisco next week. The Company is initially focused on developing...

Advertisement

First Comprehensive Study on How Physicians Use Digital Sources to Find Medical Device Information Now Available

November 4, 2011 6:33 am | News | Comments

TORONTO--(BUSINESS WIRE)--Millennium Research Group (MRG), the global authority on medical technology market intelligence, announced today that it will be marketing the Manhattan Research product Digital MedTech Physicianâ„¢, the first data-intense study of how physicians use digital channels...

Arterial Remodeling Technologies (“ART") reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

November 2, 2011 8:23 pm | News | Comments

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) reported today that in vivo data strongly suggest that its second-generation bioresorbable stent promotes positive arterial remodeling in a post-angioplasty porcine model at three months follow-up.

Medtronic Begins Transcatheter Aortic Valve Trial in Japan

November 2, 2011 8:09 pm | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the Medtronic CoreValve® System. The successful procedure in the trial was led by Professor Yoshiki Sawa

New Brain Aneurysm Treatment at Stanford Hospital Supplies Hope

November 2, 2011 4:22 am | News | Comments

STANFORD, Calif.--(BUSINESS WIRE)--If Barbara Maluo's brain aneurysm had been discovered a few months ago, she would have had few viable treatment options. She was one of the 10 to 15 percent of brain aneurysm patients diagnosed each year with aneurysms so large and wide...

ROX Medical Announces First Clinical Use of the ROX FLO2W Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients

November 1, 2011 8:42 pm | News | Comments

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--ROX Medical, Inc., a world leader in the development of unique minimally invasive medical devices for the treatment of advanced COPD and resistant hypertension, today announced the first clinical use of the ROX CO2UPLERTM at the Universitair Ziekenhuis Brussel...

Advertisement

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

October 31, 2011 9:14 am | News | Comments

MINNEAPOLIS –– Oct. 31, 2011 –– Advancing the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant® Cobalt Iliac Balloon-Expandable Stent System.

Physician Prescriptions for ZOLL LifeVest Top 50,000

October 28, 2011 10:33 am | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest® Wearable Defibrillator.

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

October 28, 2011 7:44 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic Phased RF Ablation System, the first atrial fibrillation ablation therapy under investigation...

Boston Biomedical Associates helps AtriCure's Synergy Ablation System win a Recommendation from FDA Expert Advisors

October 28, 2011 7:39 am | News | Comments

NORTHBOROUGH, Mass.--(BUSINESS WIRE)--Boston Biomedical Associates today announced that AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and devices for the exclusion of the left atrial appendage, received a vote of approval support...

Avinger Debuts Kittycat 2 Catheter and Juicebox in US and EU Markets, Two Innovative Tools for the Treatment of Peripheral Artery Disease (PAD)

October 27, 2011 11:57 am | News | Comments

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for treating patients with Peripheral Artery Disease (PAD), announces today the release of two new products, Kittycat 2, a smaller more refined ultimate support catheter, and Juicebox...

Advertisement

Medtronic Starts Landmark Study of Hypertension Treatment

October 27, 2011 11:36 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE: MDT) announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity® Renal Denervation System™ for treatment-resistant hypertension. The first patient in this landmark study was enrolled at the Prairie Heart Institute at St. John's Hospital in Springfield, Ill.

Reused pacemakers safe option in poor countries

October 27, 2011 6:09 am | News | Comments

(Reuters) - Recycled pacemakers donated from U.S. funeral homes could offer a safe way to get the heart devices to people in the developing world who otherwise might not be able to afford them, a U.S. study said. An estimated 1 million to 2 million people around the world die...

Oklahoma Pastor with Total Artificial Heart Marks 1 Year of Life at Home with Freedom Portable Driver

October 27, 2011 5:56 am | News | Comments

Tucson AZ USA -- Medical E-Mail Newsâ„¢ / Oct 26 2011 -- SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Oklahoma pastor Troy Golden has surpassed one year of life

Medtronic heart device has safety issues: FDA staff

October 25, 2011 11:28 am | News | Comments

(Reuters) - U.S. reviewers said a Medtronic Inc device was effective for treating a common heart rhythm disorder, but they raised concerns about its safety. Medtronic's Cardiac Ablation System is designed to treat persistent atrial fibrillation...

'Extreme EVAR and TEVAR' a Hot Topic at the International Symposium on Endovascular Therapy (ISET) 2012

October 25, 2011 7:27 am | News | Comments

MIAMI BEACH, Fla., Oct. 25, 2011 -- Endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) take center stage at the upcoming 24th Annual International Symposium on Endovascular Therapy (ISET), which brings together...

AtriCure heart device safe, with caveats: FDA staff

October 25, 2011 6:23 am | News | Comments

(Reuters) - AtriCure Inc's Synergy Ablation System heart-rhythm device is safe and effective, but its trial size and design raise some concerns, U.S. medical device reviewers said.

Neurosurgical and Neurovascular Device Market to Grow at Six Percent Per Year

October 25, 2011 6:01 am | News | Comments

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016...

Cook Medical's Zilver PTX Drug-Eluting Stent Technology Receives Unanimous Recommendation from FDA Advisory Committee

October 14, 2011 5:38 am | News | Comments

The Zilver® PTX® Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the FDA's Circulatory System Devices Panel of the Medical Devices Advisory Committee...

Acetylon starts multiple myeloma treatment trial

September 23, 2011 8:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Acetylon Pharmaceuticals Inc. of Boston has begun a Phase 1-2a clinical trial of its multiple myeloma treatment, ACY-1215, just on the heels of the start of a patient study by the Multiple Myeloma Research Foundation.

NxStage: NIH Study Published in New England Journal of Medicine Adds to Growing Body of Evidence in Support of More Frequent Hemodialysis

September 23, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass., Sept. 23, 2011 /- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today commented on the just-released findings of an NIH sponsored study which shows that event rates, including mortality, were significantly higher for...

Personalized multiple myeloma study of 1,000 patients starts

September 22, 2011 8:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The Multiple Myeloma Research Foundation said it has enrolled the first person in a 1,000-patient study aimed at discovering variations of the incurable blood cancer.

Cardica Achieves Milestone Under Century Distribution Agreement

September 22, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Sept. 22, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that it has achieved the first MicroCutter™ milestone under its distribution agreement and loan commitment with Century Medical, allowing Cardica to draw the first $2 million of an up to $4...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading